{"id":"https://openalex.org/W2118967594","doi":null,"title":"Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.","display_name":"Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.","alternate_titles":[],"publication_year":1997,"publication_date":"1997-10-01","ids":{"openalex":"https://openalex.org/W2118967594","mag":"2118967594","pmid":"https://pubmed.ncbi.nlm.nih.gov/9815559"},"language":"en","primary_location":{"id":"pmid:9815559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W2118967594"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111445559","display_name":"Saskia A. B. E. van Acker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"S A van Acker","raw_affiliation_strings":["Leiden Amsterdam Center for Drug Research, Division of Molecular Pharmacology, Department of Pharmacochemistry, Faculty of Chemistry, Vrije Universiteit, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leiden Amsterdam Center for Drug Research, Division of Molecular Pharmacology, Department of Pharmacochemistry, Faculty of Chemistry, Vrije Universiteit, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088663155","display_name":"Epie Boven","orcid":"https://orcid.org/0000-0001-9287-743X","observed_orcids":["https://orcid.org/0000-0001-9287-743X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Boven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108587411","display_name":"Karel K.J. Kuiper","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Kuiper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070078466","display_name":"Dirk\u2010Jan van den Berg","orcid":"https://orcid.org/0000-0002-2253-579X","observed_orcids":["https://orcid.org/0000-0002-2253-579X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D J van den Berg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082003782","display_name":"Joop A. Grimbergen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J A Grimbergen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068604572","display_name":"Klaas Kramer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Kramer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084729994","display_name":"Aalt Bast","orcid":"https://orcid.org/0000-0002-5383-2789","observed_orcids":["https://orcid.org/0000-0002-5383-2789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Bast","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5113602128","display_name":"Wim J.F. van der Vijgh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W J van der Vijgh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5097,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.66343299,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"3","issue":"10","first_page":"1747","last_page":"1754"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.925000011920929},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.9539999961853027},{"id":"https://openalex.org/keywords/flavonoids","display_name":"flavonoids","score":0.9440000057220459},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.859000027179718},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7749999761581421},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.6899999976158142},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/free-radicals","display_name":"free radicals","score":0.45100000500679016},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.6309999823570251},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.9447131752967834},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.9100558161735535},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7875609397888184},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6539323329925537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4559600353240967},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4264020621776581},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4152721166610718},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3814763128757477},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.35224223136901855},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.334536612033844},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17596429586410522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16797730326652527},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000975","descriptor_name":"Antioxidants","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D005609","descriptor_name":"Free Radicals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006896","descriptor_name":"Hydroxyethylrutoside","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006896","descriptor_name":"Hydroxyethylrutoside","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007501","descriptor_name":"Iron","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011794","descriptor_name":"Quercetin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011794","descriptor_name":"Quercetin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011794","descriptor_name":"Quercetin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011794","descriptor_name":"Quercetin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011794","descriptor_name":"Quercetin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D011929","descriptor_name":"Razoxane","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011929","descriptor_name":"Razoxane","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011929","descriptor_name":"Razoxane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011929","descriptor_name":"Razoxane","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D012431","descriptor_name":"Rutin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012431","descriptor_name":"Rutin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012431","descriptor_name":"Rutin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012431","descriptor_name":"Rutin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D013686","descriptor_name":"Telemetry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015913","descriptor_name":"Chelation Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016166","descriptor_name":"Free Radical Scavengers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018284","descriptor_name":"Cystadenocarcinoma, Serous","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D044948","descriptor_name":"Flavonols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044949","descriptor_name":"Kaempferols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"pmid:9815559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Comparative Study"},{"id":"pmh:oai:research.vu.nl:openaire_cris_publications/690f2b31-8e11-4d5c-9944-04fcff526002","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/690f2b31-8e11-4d5c-9944-04fcff526002","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van Acker, S A B E, Boven, E, Kuiper, K, van den Berg, D J, Grimbergen, J A, Kramer, K, Bast, A & van der Vijgh, W J F 1997, 'Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.', Clinical Cancer Research, vol. 3, pp. 1747-1754.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research.vu.nl:openaire_cris_publications/2a78e6b7-d0a9-4b19-8ccf-c760a9e35a38","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/2a78e6b7-d0a9-4b19-8ccf-c760a9e35a38","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Acker, S A B E, Boven, E, Kuiper, K, van den Berg, D J, Grimbergen, J A, Kramer, K, Bast, B & van der Vijgh, W J F 1997, 'Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor, activity of doxorubicin', Clinical Cancer Research, vol. 3, pp. 1747-1754.","raw_type":"article"},{"id":"pmh:oai:research.vu.nl:publications/690f2b31-8e11-4d5c-9944-04fcff526002","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/690f2b31-8e11-4d5c-9944-04fcff526002","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Acker, S A B E, Boven, E, Kuiper, K, van den Berg, D J, Grimbergen, J A, Kramer, K, Bast, A & van der Vijgh, W J F 1997, 'Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affects the antitumor activity of doxorubicin.', Clinical Cancer Research, vol. 3, pp. 1747-1754.","raw_type":"article"},{"id":"pmh:vu:oai:research.vu.nl:publications/2a78e6b7-d0a9-4b19-8ccf-c760a9e35a38","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/2a78e6b7-d0a9-4b19-8ccf-c760a9e35a38","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 3, 1747 - 1754. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu:oai:research.vu.nl:publications/690f2b31-8e11-4d5c-9944-04fcff526002","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/690f2b31-8e11-4d5c-9944-04fcff526002","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Cancer Research, 3, 1747 - 1754. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2118967594","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W52847425","https://openalex.org/W1487811436","https://openalex.org/W1502767888","https://openalex.org/W1543206714","https://openalex.org/W1549056640","https://openalex.org/W1977640845","https://openalex.org/W1985534398","https://openalex.org/W1992786087","https://openalex.org/W1996151161","https://openalex.org/W2009309397","https://openalex.org/W2011013238","https://openalex.org/W2013911067","https://openalex.org/W2047664626","https://openalex.org/W2054814252","https://openalex.org/W2055421320","https://openalex.org/W2071433940","https://openalex.org/W2094243302","https://openalex.org/W2095405979","https://openalex.org/W2103885797","https://openalex.org/W2325508287","https://openalex.org/W2395916772","https://openalex.org/W2414012265","https://openalex.org/W2414700475","https://openalex.org/W2419056831"],"related_works":["https://openalex.org/W2094243302","https://openalex.org/W1986597120","https://openalex.org/W2118675584","https://openalex.org/W2138095119","https://openalex.org/W1989268025","https://openalex.org/W2088290714","https://openalex.org/W2114627331","https://openalex.org/W958142251","https://openalex.org/W2018180569"],"abstract_inverted_index":{"The":[0,203],"cumulative":[1],"dose-related":[2],"cardiotoxicity":[3,35,114,285],"of":[4,14,33,46,70,160,198,205,214,224,251,271,293],"doxorubicin":[5,47,73,91,161,199,217,246,294],"is":[6],"believed":[7],"to":[8,30,39,90,107,117],"be":[9,118,275],"caused":[10],"by":[11],"the":[12,31,43,61,95,130,133,136,155,158,195,211,268,290],"production":[13],"oxygen-":[15],"free":[16],"radicals.":[17],"7-Monohydroxyethylrutoside":[18],"(monoHER),":[19],"a":[20,58,248,280],"semisynthetic":[21],"flavonoid":[22],"and":[23,38,50,93,123,140,164,170,185,229,264,286],"powerful":[24],"antioxidant,":[25],"was":[26,115,207,261],"investigated":[27],"with":[28,57,79,121,144,221],"respect":[29],"prevention":[32],"doxorubicin-induced":[34],"in":[36,48,51,60,77,132,135,154,162,176,227,238,247,295,298],"mice":[37,54],"its":[40],"influence":[41,194,204,289],"on":[42,210],"antitumor":[44,269,291],"activity":[45,270,292],"vitro":[49,296],"vivo.":[52,299],"Non-tumor-bearing":[53],"were":[55,65,101,148,180,233],"equipped":[56],"telemeter":[59],"peritoneal":[62],"cavity.":[63],"They":[64],"given":[66,219],"six":[67],"weekly":[68],"doses":[69],"4":[71,97],"mg/kg":[72,84,216,253],"i.v.,":[74,218],"alone":[75],"or":[76,82,157,256,297],"combination":[78],"either":[80],"100":[81,186],"250":[83],"monoHER":[85,206,278],"i.p.,":[86],"1":[87,225,243],"h":[88,244],"prior":[89],"administration":[92],"for":[94,150],"following":[96],"days.":[98],"Cardiotoxic":[99],"effects":[100,153,197],"measured":[102],"from":[103,129],"electrocardiogram":[104],"changes":[105],"up":[106],"2":[108,255],"weeks":[109],"after":[110],"treatment.":[111],"Protection":[112],"against":[113,283],"found":[116],"dose":[119,249],"dependent,":[120],"53":[122],"75%":[124],"protection,":[125],"respectively,":[126],"as":[127,235],"calculated":[128],"reduction":[131],"increase":[134],"ST":[137],"interval.":[138],"MonoHER":[139],"several":[141],"other":[142],"flavonoids":[143,179],"good":[145],"antioxidant":[146],"properties":[147],"tested":[149,209],"their":[151],"antiproliferative":[152,196],"absence":[156],"presence":[159],"A2780":[163,228],"OVCAR-3":[165,230],"human":[166,172],"ovarian":[167],"cancer":[168,174],"cells":[169,175,231],"MCF-7":[171],"breast":[173],"vitro.":[177],"Some":[178],"directly":[181],"toxic":[182,263],"at":[183,200],"50":[184],"microM,":[187],"whereas":[188],"others,":[189],"including":[190],"monoHER,":[191],"did":[192,265,287],"not":[193,262,266,288],"these":[201],"concentrations.":[202],"further":[208],"growth-inhibitory":[212],"effect":[213],"8":[215],"twice":[220],"an":[222],"interval":[223],"week":[226],"that":[232,277],"grown":[234],"s.c.":[236],"xenografts":[237],"nude":[239],"mice.":[240],"MonoHER,":[241],"administered":[242],"before":[245],"schedule":[250],"500":[252],"i.p.":[254],"5":[257],"days":[258],"per":[259],"week,":[260],"decrease":[267],"doxorubicin.":[272],"It":[273],"can":[274],"concluded":[276],"showed":[279],"dose-dependent":[281],"protection":[282],"chronic":[284]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2118967594","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
